Lightnews — Scholar-powered news

Reposted by Martin Ugander

David Winchester @drdavemd.bsky.social · 21d

Accuracy of #AI based measurements on echocardiography www.jacc.org/doi/10.1016/... #cardiosky @jaccjournals.bsky.social

2

Martin Ugander @mugander.bsky.social · 25d

More about likelihood ratios in diagnostic testing:

Jaeschke R, et al, JAMA, 1994.
www.pubmed.gov/8309035

Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Workin...

www.pubmed.gov

Martin Ugander @mugander.bsky.social · 25d

Interpretation for both LR+ and ILR- in terms of how conclusive the test changes pretest to posttest likelihood of a positive (or negative) finding:

>10 = large
5-10 = moderate
2-5 = small but sometimes important
<2 = inconclusive

1

Martin Ugander @mugander.bsky.social · 25d

Inverse negative likelihood ratio (ILR-) = 1/LR- = specificity / (1-sensitivity) = 92.3% / (1-41.2%) = 1.6 = how many more times likely it is that you do NOT have the disease in question thanks to the test

1

Martin Ugander @mugander.bsky.social · 25d

Positive likelihood ratio (LR+) = sensitivity / (1-specificity) = 41.2% / (1-92.3%) = 5.4 = how many more times likely it is that you have the disease in question thanks to the test

1

Martin Ugander @mugander.bsky.social · 25d

However, sens and spec values are highly dependent on disease prevalence in the population being studied. The measures of test performance that are independent of population disease prevalence are likelihood ratios, which tell us how many times more likely a diagnosis is after applying a test.

1

Martin Ugander @mugander.bsky.social · 25d

In Apple’s white paper on their Hypertension Notification Feature for Apple Watch, they report low sensitivity (41.2%) and high specificity (92.3%). They rightfully chose a threshold for notification while seeking to keep the false positive rate low.

The white paper: www.apple.com/health/pdf/H...

www.apple.com

1

Martin Ugander @mugander.bsky.social · 25d

Read on if you are interested in (the Apple Watch) diagnostic test performance.

It's all about the likelihood ratios.

1

Martin Ugander @mugander.bsky.social · 25d

I still applaud Apple and think the Hypertension Notification feature will be useful for the individual and society. Any nudge that can help early identification of hypertension is valuable, especially when it is passively integrated into everyday use of a consumer device as implemented by Apple.

1

Martin Ugander @mugander.bsky.social · 25d

In other words, you should NOT rest on your laurels and assume that you don't have hypertension. Get your blood pressure tested regularly regardless, because hypertension is very common, deadly in the long term, and highly treatable.

1

Martin Ugander @mugander.bsky.social · 25d

If you do NOT get a Hypertension Notification despite using your watch, then you are NO MORE LIKELY to be free of hypertension than before you used your watch (inverse negative likelihood ratio 1.6, which is inconclusive).

1

Martin Ugander @mugander.bsky.social · 25d

If you get an Apple Watch Hypertension Notification, then you are 5 TIMES MORE LIKELY to have hypertension than if you didn't use your watch (LR+ 5.4). This is moderately useful test information. You should definitely get your blood pressure tested.

A thread..

#CardioSky
#MedSky
#Apple
#AppleWatch

2 2

Martin Ugander @mugander.bsky.social · Sep 13

Very much so, in a way that has surprised me. We are currently studying this prospectively.

Martin Ugander @mugander.bsky.social · Sep 13

Not at all. I rather like the approach, which can be done without compromising scientific rigor, as in the following paper from our group.

PubMed.gov/39846063

Advanced electrocardiography heart age: a prognostic, explainable machine learning approach applicable to sinus and non-sinus rhythms - PubMed

An explainable A-ECG Heart Age gap applicable to both sinus and non-sinus rhythm associates with cardiovascular risk, cardiovascular morbidity, and survival.

PubMed.gov

1 1

Martin Ugander @mugander.bsky.social · Aug 27

Different roles, often overlapping, all there hopefully to help.

#mentor
#coach
#supervisor
#boss
#rolemodel
#advocate
#sponsor

#MedSky
#AcademicSky
#mentorship

Mentor – senior person that broadly knows your field and gives you specific advice

Coach – does not need to know your field, and asks you questions to help you guide yourself to do what you want to do, without necessarily giving you specific advice

Supervisor – the person you report to and are accountable to in your work, dependency relationship

Boss – is often the Supervisor, but may be one or more steps up in hierarchy, the one who hires and fires and pays your salary

Role model – someone you look to for inspiration and wish to emulate

Advocate – promotes you and your interests, perhaps by praising your work in a meeting

Sponsor – actively invests in your growth, perhaps by using their influence to provide opportunities for advancement even when you are not in the room

1 4

Martin Ugander @mugander.bsky.social · Aug 22

In our experience, "accelerated aging" measured in years of healthy human aging is a unit of measurement that has unsurpassed clarity of understanding among the general public (patients). We need to be more 'tabloid' to get our message across, imho.

1 1

Martin Ugander @mugander.bsky.social · Aug 15

John Greenwood bringing it home on #WhyCMR vs #CVnuc for myocardial perfusion imaging. #CardioSky

1 2

Martin Ugander @mugander.bsky.social · Aug 14

#CardioSky #WhyCMR #EchoFirst

1

Reposted by Martin Ugander

rebeccakozor.bsky.social @rebeccakozor.bsky.social · Aug 14

Imaging of aortic regurgitation presented eloquently by @JoaoLCavalcante #CSANZ2025
🤝poor agreement b/t echo & CMR
💰big price to pay when AR labelled moderate
🧲use CMR to accurately assess AR

#ANZCMR #whyCMR @scmrorg.bsky.social

1 2 2

Reposted by Martin Ugander

rebeccakozor.bsky.social @rebeccakozor.bsky.social · Aug 10

Thursday #CSANZ2025 is packed with so many great meetings! I’ll be going between the imaging, heart failure and genetics meetings. Which one will you attend? @anastasiasmihaili.bsky.social @mugander.bsky.social

1 3 4

Martin Ugander @mugander.bsky.social · Jul 20

We don’t yet have definitive data on it, but the non-LAVI (c) formula is likely best for short-term changes in PAWP, whereas (b) is just as good in stable hemodynamics, and (a) is good enough if you haven’t acquired PV velocities.

2 1

Martin Ugander @mugander.bsky.social · Jul 20

We have actually have three formulas for estimating PAWP.
From Lindow 2024 using:
a) E + LAVI
b) E + PVs + LAVI
and from Lindow 2025 using
c) E + PVs + PVd
Their accuracy, precision and prognostic association are presented in each paper.

1 1

Martin Ugander @mugander.bsky.social · Jul 5

Both HFpEF and HFrEF were included. However, it was limited to those with at most mild mitral regurgitation or stenosis, and sinus rhythm.

More details are in the paper.

academic.oup.com/ehjimp/artic...

Echocardiography can accurately estimate pulmonary artery wedge pressure without left atrial volume information—diagnostic and prognostic performance

AbstractAims. A quantitative estimate of pulmonary artery wedge pressure (PAWP) can be obtained using echocardiography, but including left atrial (LA) volu

academic.oup.com

2 2

Martin Ugander @mugander.bsky.social · Jun 22

Beware the Four Fallacies of (Dis)Loyalty.

In providing career guidance, mentoring and coaching to academics, aspects of loyalty and holding grudges (disloyalty) often come up. This has provided structure to some of these conversations.

#AcademicSky
#PhDSky
#LeadershipSky
#MentorSky
#CoachSky

1 6 15

Reposted by Martin Ugander

David Winchester @drdavemd.bsky.social · Jun 18

Tirzepatide reduces LV mass and paracardiac adipose tissue, a potential mechanism for reduced HF events in SUMMIT @jaccjournals.bsky.social @chriskramermd.bsky.social www.jacc.org/doi/10.1016/...

Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy

www.jacc.org

3 2